Critical heart drug too pricey for some Medicare patients

(University of Hawaii at Manoa) An effective drug to treat chronic heart failure may cost too much for senior citizens with a standard Medicare Part D drug plan, said a study co-authored by a John A. Burns School of Medicine researcher at the University of Hawaii at Manoa. The therapy is a combination of sacubitril/valsartan called Entresto ® . Researchers found that, even with insurance, the cost to Medicare patients may be more than $1,600 a year.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news